Patrick L. Mulcrone

758 total citations
24 papers, 565 citations indexed

About

Patrick L. Mulcrone is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Patrick L. Mulcrone has authored 24 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Patrick L. Mulcrone's work include Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Patrick L. Mulcrone is often cited by papers focused on Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Patrick L. Mulcrone collaborates with scholars based in United States, Switzerland and Mexico. Patrick L. Mulcrone's co-authors include Julie A. Sterling, Masatoshi Suzuki, Florent Elefteriou, Clive N. Svendsen, Genevíève Gowing, Michaël Meyer, Philip Owens, Patrick Aebischer, Alyssa R. Merkel and Chad Zimprich and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Patrick L. Mulcrone

23 papers receiving 560 citations

Peers

Patrick L. Mulcrone
Michael Tobias United States
Hyoung Kyun Rha South Korea
Mark W. Youngblood United States
Ken Morii Japan
Esther Kur Germany
Timothy W. Vogel United States
Ali Jalali United States
Michael Tobias United States
Patrick L. Mulcrone
Citations per year, relative to Patrick L. Mulcrone Patrick L. Mulcrone (= 1×) peers Michael Tobias

Countries citing papers authored by Patrick L. Mulcrone

Since Specialization
Citations

This map shows the geographic impact of Patrick L. Mulcrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick L. Mulcrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick L. Mulcrone more than expected).

Fields of papers citing papers by Patrick L. Mulcrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick L. Mulcrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick L. Mulcrone. The network helps show where Patrick L. Mulcrone may publish in the future.

Co-authorship network of co-authors of Patrick L. Mulcrone

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick L. Mulcrone. A scholar is included among the top collaborators of Patrick L. Mulcrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick L. Mulcrone. Patrick L. Mulcrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Junping, Dylan Frabutt, Ning Li, et al.. (2024). A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR. Molecular Therapy — Methods & Clinical Development. 32(1). 101206–101206. 4 indexed citations
3.
Miyagawa, Kazuaki, Patrick L. Mulcrone, Jesús Delgado‐Calle, et al.. (2023). Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation. JCI Insight. 8(14). 6 indexed citations
4.
Mulcrone, Patrick L., Dylan Frabutt, Junping Zhang, et al.. (2023). Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism. Scientific Reports. 13(1). 8436–8436. 10 indexed citations
5.
Mulcrone, Patrick L., Dylan Frabutt, Junping Zhang, et al.. (2023). Comprehensive Comparison of AAV Purification Methods: Iodixanol Gradient Centrifugation vs. Immuno-Affinity Chromatography. PubMed. 2023. 1–12. 10 indexed citations
6.
Zhang, Junping, Dylan Frabutt, Patrick L. Mulcrone, et al.. (2022). Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS. Molecular Therapy — Methods & Clinical Development. 27. 185–194. 17 indexed citations
7.
Mulcrone, Patrick L., Roland W. Herzog, & Weidong Xiao. (2022). Adding recombinant AAVs to the cancer therapeutics mix. Molecular Therapy — Oncolytics. 27. 73–88. 6 indexed citations
8.
Zhang, Junping, Dylan Frabutt, Patrick L. Mulcrone, et al.. (2022). Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes. Molecular Therapy — Nucleic Acids. 29. 852–861. 17 indexed citations
9.
Mulcrone, Patrick L., et al.. (2022). Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice. PubMed. 2022. 1–19. 4 indexed citations
10.
Zhang, Junping, Matthew Chrzanowski, Dylan Frabutt, et al.. (2022). Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors. Journal of Medical Virology. 95(1). e28433–e28433. 2 indexed citations
11.
Petrusca, Daniela N., Patrick L. Mulcrone, Ryan T. Bishop, et al.. (2022). GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival. Cancers. 14(3). 772–772. 10 indexed citations
12.
Bhatti, Fazal‐Ur‐Rehman, Stephen K. Mendenhall, Donghui Zhou, et al.. (2021). The effects of bone morphogenetic protein 2 and thrombopoietin treatment on angiogenic properties of endothelial cells derived from the lung and bone marrow of young and aged, male and female mice. The FASEB Journal. 35(9). e21840–e21840. 9 indexed citations
13.
Mulcrone, Patrick L., et al.. (2020). Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23. PMC. 1 indexed citations
14.
Mulcrone, Patrick L., et al.. (2020). Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23. Scientific Reports. 10(1). 17319–17319. 24 indexed citations
15.
Mulcrone, Patrick L., et al.. (2018). β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner. Journal of bone oncology. 13. 1–10. 23 indexed citations
16.
Lee, Changki, Young Mi Whang, Patrick L. Mulcrone, et al.. (2017). Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis. Cancer Letters. 414. 205–213. 52 indexed citations
17.
Mulcrone, Patrick L., et al.. (2016). The Bone Microenvironment: a Fertile Soil for Tumor Growth. Current Osteoporosis Reports. 14(4). 151–158. 53 indexed citations
18.
Campbell, James, Patrick L. Mulcrone, Alyssa R. Merkel, et al.. (2015). TRIzol and Alu qPCR-based quantification of metastatic seeding within the skeleton. Scientific Reports. 5(1). 12635–12635. 29 indexed citations
19.
Mulcrone, Patrick L., Michaël Meyer, Christina Lewis, et al.. (2013). Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model. Molecular Therapy. 21(8). 1602–1610. 105 indexed citations
20.
Nichols, Nicole L., Genevíève Gowing, Irawan Satriotomo, et al.. (2012). Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis. American Journal of Respiratory and Critical Care Medicine. 187(5). 535–542. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026